Caribou Biosciences (CRBU) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | Oct 8, 2026 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 from $4.00 | Oct 7, 2026 |
| RBC Capital | Downgraded | Outperform → Sector Perform | $1.00 from $10.00 | Oct 7, 2026 |
| Brookline Capital | Downgraded | Buy → Hold | — | Oct 7, 2026 |
| B of A Securities | Maintained | Buy | $5.00 from $6.00 | Aug 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $9.00 | May 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Apr 7, 2026 |
| Evercore ISI Group | Maintained | Outperform | $13.00 from $11.00 | Mar 9, 2026 |
| Clear Street | Initiated Coverage | Buy | $13.00 | Feb 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 from $3.00 | Nov 5, 2025 |
| Citigroup | Maintained | Buy | $8.00 from $5.00 | Nov 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 from $9.00 | Apr 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Mar 19, 2025 |
| B of A Securities | Maintained | Buy | $11.00 from $13.00 | Jan 7, 2025 |
| Citigroup | Maintained | Buy | $6.00 from $30.00 | Nov 26, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Nov 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Sep 3, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Aug 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Jul 17, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 from $24.00 | Jun 4, 2024 |
Frequently asked questions
What is the price target for CRBU stock?
The average 12-month analyst price target for Caribou Biosciences (CRBU) is $2.33, with a high estimate of $5.00 and a low of $1.00, across 3 analysts.
Is CRBU a buy, sell, or hold?
Analysts covering Caribou Biosciences currently average a Buy rating: 3 buy, 3 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CRBU?
The average price target of $2.33 implies 407.14% upside from the last price of $0.46.
What is the latest analyst rating on CRBU?
On Oct 8, 2026, HC Wainwright & Co. downgraded Caribou Biosciences to Neutral.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.